Cinnarizine API Manufacturers & Suppliers

Looking for Cinnarizine API 298-57-7?

Description:

Here you will find a list of producers, manufacturers and distributors of Cinnarizine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Cinnarizine 

Synonyms:

Cinarizina , Cinnarizin , Cinnarizine , Cinnarizinum  

Cas Number:

298-57-7 

DrugBank number:

DB00568 

Unique Ingredient Identifier:

3DI2E1X18L

Cinnarizine is a type of Anti-vertigo agents

Anti-vertigo agents are a category of pharmaceutical active pharmaceutical ingredients (APIs) that are used to treat vertigo, a condition characterized by a sensation of dizziness, spinning, or loss of balance. These APIs are specifically designed to target the underlying causes of vertigo and provide relief to patients suffering from this debilitating condition.

The primary mechanism of action of anti-vertigo agents involves their ability to modulate the central nervous system (CNS) and peripheral vestibular system. By acting on specific receptors and neurotransmitters in the brain and inner ear, these APIs help regulate the balance and coordination signals transmitted by the vestibular system, thus reducing the symptoms of vertigo.

Some commonly used anti-vertigo APIs include meclizine, betahistine, and dimenhydrinate. Meclizine, for instance, is an antihistamine that blocks histamine receptors in the brain and effectively alleviates vertigo symptoms. Betahistine, on the other hand, acts as a histamine H1 receptor agonist and H3 receptor antagonist, improving blood flow in the inner ear and reducing the frequency and severity of vertigo episodes. Dimenhydrinate, a combination of diphenhydramine and 8-chlorotheophylline, exerts its anti-vertigo effects by blocking histamine receptors and exerting a sedative effect on the CNS.

Anti-vertigo agents are available in various formulations, including oral tablets, sublingual tablets, and transdermal patches, providing options for patients with different preferences and needs. These APIs have shown efficacy in managing vertigo and are commonly prescribed by healthcare professionals. However, it is important to note that these medications may have potential side effects, such as drowsiness, dry mouth, or gastrointestinal disturbances, which should be considered when prescribing them to patients.

In conclusion, anti-vertigo agents are a vital category of pharmaceutical APIs that play a crucial role in the management of vertigo. By targeting the underlying causes of this condition, these APIs provide symptomatic relief and improve the quality of life for individuals suffering from vertigo.

• SETV Global from India, product country of origin India
• Hikal from India, product country of origin India
• Unnati Pharmaceuticals Pvt Ltd from India, product country of origin India
• Fleming Labs. from India, product country of origin India
• Gedeon Richter from Hungary, product country of origin Hungary
• Vasudha Pharma Chem Ltd. from India, product country of origin India
• Indukern Chemie AG from Switzerland, product country of origin Unknown
• Janssen Pharma from Belgium, product country of origin Unknown

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.